Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting 2022-11-07 23:25
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research--Findings to be Presented at SITC 2022 2022-11-07 21:00
Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting 2022-11-07 14:38
Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA 2022-11-07 07:00
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study 2022-11-07 06:48
TurtleTree to Represent Singapore at UN Climate Change Conference 2022 as Official Drink Partner 2022-11-05 02:53
Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases 2022-11-04 20:00
NSW Health & Cicada Innovations celebrate Australia's biggest health startup training program with 1.1k participants in first year 2022-11-04 11:35
LUMC to Fund New Clinical Trial of Cynata's Cymerus™ MSCs in Kidney Transplantation 2022-11-04 09:15
Aquavit Celebrates Judgment Imposing Permanent Ban On Counterfeiters 2022-11-04 01:37
Kira Pharmaceuticals Presents Complete Data from Phase 1 SYNERGY-1 Trial of KP104 at American Society for Nephrology Kidney Week 2022 2022-11-03 21:30
Gracell Biotechnologies to Present First Clinical Data of FasTCAR-T GC012F for Newly Diagnosed Multiple Myeloma at 64th American Society of Hematology Annual Meeting & Exposition 2022-11-03 21:10
Yuyu Pharma attendance at European Pharmaceutical Conference 2022-11-03 21:00
Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon Formulation 2022-11-03 19:00
DOUBLE HONORS FOR AMGEN WITH GREAT PLACE TO WORK™ CERTIFICATIONS FOR BOTH ITS SINGAPORE ENTITIES IN 2022 2022-11-03 16:43
NeuroXess Shares Latest Breakthoughs in Life Sciences at Sequoia Talk 2022-11-03 15:03
Turn Biotechnologies Names 25-year Biotech Industry Veteran Richard Peterson Chief Financial Officer 2022-11-02 21:00
Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China 2022-11-02 20:07
Dr Amit Kakar joins MedGenome Board of Directors 2022-11-02 10:00
Ascletis Announces U.S. IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19 2022-11-02 08:10
1 104 105 106 107 108 413